Bracewell Represents Syntrix in $96 Million DNA Patent Suit

Bracewell & Giuliani LLP won a federal jury verdict in a patent suit on behalf of Syntrix, a biotechnology research firm, against Illumina in the U.S. District Court for the Western District of Washington before U.S. District Judge Benjamin H. Settle.

Syntrix first filed the suit in November 2010, alleging that Illumina sales of its BeadChip products infringed U.S. Patent 6,951,682. After an 11 day trial, the jury awarded Syntrix $95,795,507 in damages and a 6 percent royalty rate.

Bracewell attorneys who worked on this matter include:

Partners: Alan D Albright and Michael R. Samardzija

Associates: Heather Khassian, Karthika Perumal, Christopher Schenck, and Lucy Tyson

www.bracewellgiuliani.com